Rep. Joe Crowley whose name has been floated as a challenger to Nancy Pelosi lauded the embattled House Democratic leader on Sunday as a “tough cookie” and a modern-day “Caesar.” “This is one of the smartest and hardest-working members. If we were living during the Roman E mpire, she would be a centurion’s centurion. In...
NYS Entity Status
NYS Filing Date
DECEMBER 23, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC PROFESSIONAL CORPORATION
2013 - CENTURION PHYSICAL THERAPY AND ASSOCIATES, P.C.
Around the Web
- Potential Pelosi replacement compares ‘tough cookie’ Dem to ‘Caesar’
By Mark Moore - Sunday Jun 25, 2017
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]
- The Rebuilding Years, Post-Sandy
By THE NEW YORK TIMES and JONAH MARKOWITZ - Sunday Oct 29, 2017
Those affected by Hurricane Sandy five years ago shared how the storm changed their lives physically, emotionally and financially, and how things have changed for the better since.
- New Skin for 7-Year-Old Boy Marks Advance in Gene Therapy
Wednesday Nov 8, 2017
In a significant advance in organ regeneration and gene therapy, researchers created a new, healthy skin that covers almost the entire body of a 7-year-old boy with a life-threatening genetic disorder associated with skin blistering.
- FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
By Ben Fidler - Tuesday Aug 29, 2017
The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]